Collectively, genetic ablation or pharmacological inhibition of tyrosine kinase FER in ovarian cancer cells leads to decreased global tyrosine phosphorylation and PIK3R2 recruitment of IRS4, which is consistent with our ectopic overexpression studies in HEK293FT cells (Figure 5H). The gene discussed is IRS4; the disease is ovarian cancer.